Sign in

Bills › 88th General Assembly

SF 2342Died when the session ended · February 20, 2020

Relating to insurance coverage for diagnostic breast cancer examinations, and including applicability provisions

Topics:Insurance

Write your legislators about it
Official bill pageLobbyist declarationsOne-pager to print

Where it is now

  1. Done: IntroducedFebruary 20, 2020
  2. Skipped: SubcommitteeSkipped
  3. Done: Senate committeeFebruary 20, 2020
  4. Stopped: Passes the SenateDied when the General Assembly ended
  5. Next: House committee
  6. Next: Passes the House
  7. Next: To the Governor
  8. Next: Signed into law

Died when the session ended The General Assembly adjourned on June 14, 2020. Bills that didn’t pass both chambers died. What’s a funnel?

Fiscal note

Cost: up to $129,000 Compare with other bills

The fiscal impact of SF 2342 for shifting the share of costs associated with diagnostic breast cancer examinations from Plan members to the Plan is approximately $122,000 in FY 2021 and $129,000 in FY 2022. 1% of the total amount paid by the State of Iowa Plan for medical and pharmaceutical expenses.

Nonpartisan cost estimates from the Legislative Services Agency’s Fiscal Services Division. The newest is first. Reading a fiscal note